S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: trastuzumab|DRUG: docetaxel|DRUG: vinorelbine
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)